American Century Companies’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.7M Buy
70,830
+8,235
+13% +$697K ﹤0.01% 1905
2026
Q1
$6.22M Buy
62,595
+47,049
+303% +$6.14M ﹤0.01% 1669
2025
Q4
$1.89M Buy
+15,546
New +$1.95M ﹤0.01% 2105
2024
Q2
Sell
-295,606
Closed -$21.9M 2949
2024
Q1
$21.9M Sell
295,606
-212,474
-42% -$17.5M 0.01% 893
2023
Q4
$40.1M Buy
508,080
+21,124
+4% +$1.27M 0.03% 582
2023
Q3
$26.7M Buy
486,956
+355,755
+271% +$25.6M 0.02% 699
2023
Q2
$11M Sell
131,201
-114,632
-47% -$8.78M 0.01% 1018
2023
Q1
$18.6M Sell
245,833
-134,949
-35% -$9.33M 0.01% 782
2022
Q4
$23.5M Buy
+380,782
New +$20.2M 0.02% 665

Other funds holding TMDX

American Century Companies's TMDX Position: Q2 2026 in Review

American Century Companies increased its Transmedics (TMDX) stake by 13% in Q2 2026, buying an estimated $697K and bringing the position to 70,830 shares worth $4.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1905.

American Century Companies first reported a position in TMDX in Q4 2022 and has held it in 9 quarters since. The position peaked at $40.1M in Q4 2023. 347 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • American Century Companies held 70,830 shares of Transmedics worth $4.7M as of Q2 2026.
  • American Century Companies bought 8,235 Transmedics shares in Q2 2026, an estimated $697K.
  • Transmedics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1905 holding.
  • American Century Companies first reported a position in Transmedics in Q4 2022 and has held it in 9 quarters since.
  • American Century Companies's Transmedics position peaked at $40.1M in Q4 2023.
  • 347 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.